Organ preservation following radiation therapy and concurrent intra-arterial low dose cisplatin infusion for advanced T2 and T3 laryngeal cancer: Long-term clinical results from a pilot study

Laryngoscope Investigative Otolaryngology
Takeharu OnoHirohito Umeno

Abstract

This pilot study evaluated the long-term outcomes of patients with advanced T2 or T3 squamous cell carcinoma of the larynx (SCC-L) who were treated with selective intra-arterial cisplatin and concomitant radiotherapy (RADPLAT). We retrospectively investigated the data of 49 patients with advanced T2 or T3 SCC-L who received a RADPLAT regimen with low-dose cisplatin. The 5-year locoregional control, disease-specific survival, and overall survival rates were 83.3%, 88.1%, and 82.6%, respectively, while the 5-year freedom from laryngectomy, laryngectomy-free survival, and laryngo-esophageal dysfunction-free survival rates were 89.6%, 79.4%, and 77.1%, respectively. The incidences of grade 3-4 hematologic and nonhematologic toxicities were 18% and 6%, respectively. Although two patients (4%) developed late toxicities within 5 years following RADPLAT, no other events were noted beyond 5 years. This pilot study demonstrated that RADPLAT is feasible and safe and yielded favorable survival outcomes and functional laryngeal preservation in patients with advanced T2 or T3 SCC-L. 3.

References

Dec 3, 2003·The New England Journal of Medicine·Arlene A ForastiereJay Cooper
Feb 6, 2007·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Federico L AmpilEdward Milligan
Apr 7, 2007·American Journal of Clinical Oncology·Russell W HinermanDouglas B Villaret
Jun 24, 2008·Otolaryngologic Clinics of North America·Nishant Agrawal, Patrick K Ha
Apr 21, 2009·The Annals of Otology, Rhinology, and Laryngology·Tomokazu YoshizakiOsamu Matsui
Apr 28, 2009·International Journal of Radiation Oncology, Biology, Physics·Louise LambertPhuc Felix Nguyen-Tan
Jul 22, 2011·The Annals of Otology, Rhinology, and Laryngology·Hisashi SugimotoTomokazu Yoshizaki
Nov 22, 2011·International Journal of Radiation Oncology, Biology, Physics·Abrahim Al-MamganiPeter C Levendag
Sep 8, 2012·The Annals of Otology, Rhinology, and Laryngology·Naohiro WakisakaTomokazu Yoshizaki
Nov 28, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arlene A ForastiereJay S Cooper
Jan 3, 2013·The Laryngoscope·Kenichiro NomuraYasuaki Harabuchi
Jun 5, 2013·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·A Al-MamganiR J Baatenburg de Jong
Aug 22, 2014·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Małgorzata LeszczyńskaWitold Szyfter
Aug 22, 2014·JAMA Otolaryngology-- Head & Neck Surgery·Uchechukwu C Megwalu, Andrew G Sikora
May 21, 2015·The Annals of Otology, Rhinology, and Laryngology·David W TimmeK Thomas Robbins
Nov 30, 2016·CA: a Cancer Journal for Clinicians·Conor E SteuerNabil F Saba

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

JMP Pro
RADPLAT

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.